Martin Patricia A. — SEC Form 4 filings
SEC reporting owner CIK 1916764. 17 Form 4 filings on record with FilingPulse; latest filed 2026-07-10.
Transaction summary — filings shown
Covers all 17 filings on record, filed 2024-01-31 to 2026-07-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | Director | 11 | — | — | 16 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | Director | 6 | — | — | 9 |
Form 4 filings — Martin Patricia A.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-10 | 4 | AN2 Therapeutics, Inc. (ANTX) | Grant/award (A): 766 @ $0 | EDGAR |
| 2026-07-02 | 4 | CYPHERPUNK TECHNOLOGIES INC. (CYPH) | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2026-04-10 | 4 | AN2 Therapeutics, Inc. (ANTX) | Grant/award (A): 1,192 @ $0 | EDGAR |
| 2026-03-23 | 4 | AN2 Therapeutics, Inc. (ANTX) | Grant/award (A): 24,999 (derivative) · Disposition to issuer (D): 24,999 (derivative) · Grant/award (A): 10,362 (derivative) · Disposition to issuer (D): 10,362 (derivative) · Grant/award (A): 23,742 (derivative) · Disposition to issuer (D): 23,742 (derivative) | EDGAR |
| 2026-03-17 | 4 | CYPHERPUNK TECHNOLOGIES INC. (CYPH) | Option exercise (M): 74,700 · Option exercise (M): 94,050 · Option exercise (M): 74,700 (derivative) @ $0 · Option exercise (M): 94,050 (derivative) @ $0 | EDGAR |
| 2026-02-23 | 4 | AN2 Therapeutics, Inc. (ANTX) | Grant/award (A): 20,400 (derivative) @ $0 | EDGAR |
| 2026-01-14 | 4 | AN2 Therapeutics, Inc. (ANTX) | Grant/award (A): 3,650 @ $0 | EDGAR |
| 2025-12-30 | 4 | CYPHERPUNK TECHNOLOGIES INC. (CYPH) | Grant/award (A): 94,050 (derivative) @ $0 | EDGAR |
| 2025-11-13 | 4 | CYPHERPUNK TECHNOLOGIES INC. (CYPH) | Grant/award (A): 74,700 (derivative) @ $0 | EDGAR |
| 2025-10-14 | 4 | AN2 Therapeutics, Inc. (ANTX) | Grant/award (A): 3,274 @ $0 | EDGAR |
| 2025-07-11 | 4 | AN2 Therapeutics, Inc. (ANTX) | Grant/award (A): 3,750 @ $0 | EDGAR |
| 2025-05-23 | 4 | AN2 Therapeutics, Inc. (ANTX) | Grant/award (A): 19,111 (derivative) @ $0 | EDGAR |
| 2025-04-11 | 4 | AN2 Therapeutics, Inc. (ANTX) | Grant/award (A): 3,065 @ $0 | EDGAR |
| 2024-12-23 | 4 | AN2 Therapeutics, Inc. (ANTX) | Grant/award (A): 3,166 @ $0 | EDGAR |
| 2024-10-04 | 4 | LEAP THERAPEUTICS, INC. (LPTX) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | AN2 Therapeutics, Inc. (ANTX) | Grant/award (A): 64,503 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | LEAP THERAPEUTICS, INC. (LPTX) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1916764 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →